NCT00453440View on ClinicalTrials.gov

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701

CompletedOBSERVATIONAL
Enrollment

1,502

Participants

Timeline

Start Date

March 20, 2007

Primary Completion Date

August 10, 2007

Study Completion Date

August 10, 2007

Conditions
Infection, Human Immunodeficiency Virus
Interventions
PROCEDURE

Cheek swab & blood test

Cheek swab \& blood test

Trial Locations (8)

SE18 4QH

GSK Investigational Site, Woolwich, London

B4 6DH

GSK Investigational Site, Birmingham

WS2 9PS

GSK Investigational Site, Birmingham

E1 1BB

GSK Investigational Site, London

E9 6SR

GSK Investigational Site, London

SE1 7EH

GSK Investigational Site, London

SW17 0QT

GSK Investigational Site, London

W2 1NY

GSK Investigational Site, London

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY